

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 6.39167332 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.01373182 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.01373182 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.88540864 |
| 5 | regulation of water loss via skin (GO:0033561) | 4.75074718 |
| 6 | establishment of skin barrier (GO:0061436) | 4.69273094 |
| 7 | protein retention in ER lumen (GO:0006621) | 4.67716777 |
| 8 | exocrine pancreas development (GO:0031017) | 4.60662419 |
| 9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.38245768 |
| 10 | hemidesmosome assembly (GO:0031581) | 4.15544467 |
| 11 | digestion (GO:0007586) | 4.06819824 |
| 12 | multicellular organismal water homeostasis (GO:0050891) | 3.91620246 |
| 13 | intestinal cholesterol absorption (GO:0030299) | 3.74382110 |
| 14 | positive regulation of vesicle fusion (GO:0031340) | 3.54104463 |
| 15 | thyroid hormone generation (GO:0006590) | 3.45809184 |
| 16 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.44108627 |
| 17 | intestinal epithelial cell development (GO:0060576) | 3.43670282 |
| 18 | sensory perception of smell (GO:0007608) | 3.40253151 |
| 19 | keratinocyte development (GO:0003334) | 3.39825050 |
| 20 | regulation of phospholipase A2 activity (GO:0032429) | 3.24549978 |
| 21 | water homeostasis (GO:0030104) | 3.23845937 |
| 22 | sphingoid metabolic process (GO:0046519) | 3.17751364 |
| 23 | ER overload response (GO:0006983) | 3.17269731 |
| 24 | glandular epithelial cell differentiation (GO:0002067) | 3.12802384 |
| 25 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.00295962 |
| 26 | transcytosis (GO:0045056) | 2.99970999 |
| 27 | skin morphogenesis (GO:0043589) | 2.96141157 |
| 28 | thyroid hormone metabolic process (GO:0042403) | 2.92658414 |
| 29 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.90886612 |
| 30 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.90789488 |
| 31 | sphingosine metabolic process (GO:0006670) | 2.88792143 |
| 32 | protein targeting to Golgi (GO:0000042) | 2.88033273 |
| 33 | cell communication involved in cardiac conduction (GO:0086065) | 2.85604744 |
| 34 | membrane budding (GO:0006900) | 2.84564671 |
| 35 | COPII vesicle coating (GO:0048208) | 2.81342650 |
| 36 | detection of calcium ion (GO:0005513) | 2.79863576 |
| 37 | diol metabolic process (GO:0034311) | 2.78784051 |
| 38 | keratinocyte proliferation (GO:0043616) | 2.78591221 |
| 39 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.75446519 |
| 40 | hypotonic response (GO:0006971) | 2.75339872 |
| 41 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.74400286 |
| 42 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.72152705 |
| 43 | keratinization (GO:0031424) | 2.68165279 |
| 44 | macroautophagy (GO:0016236) | 2.64004136 |
| 45 | signal peptide processing (GO:0006465) | 2.62882941 |
| 46 | protein maturation by protein folding (GO:0022417) | 2.62815486 |
| 47 | cardiac conduction (GO:0061337) | 2.59709880 |
| 48 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.59203049 |
| 49 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.58857954 |
| 50 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.58574380 |
| 51 | negative regulation of fatty acid transport (GO:2000192) | 2.57909911 |
| 52 | protein localization to Golgi apparatus (GO:0034067) | 2.56532042 |
| 53 | sensory perception of chemical stimulus (GO:0007606) | 2.54539076 |
| 54 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.54288104 |
| 55 | peptide hormone processing (GO:0016486) | 2.52398945 |
| 56 | membrane repolarization during action potential (GO:0086011) | 2.52253984 |
| 57 | positive regulation of nuclease activity (GO:0032075) | 2.51667389 |
| 58 | potassium ion homeostasis (GO:0055075) | 2.50742229 |
| 59 | keratinocyte differentiation (GO:0030216) | 2.49965644 |
| 60 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.49755627 |
| 61 | icosanoid secretion (GO:0032309) | 2.49219961 |
| 62 | arachidonic acid secretion (GO:0050482) | 2.49219961 |
| 63 | endocrine pancreas development (GO:0031018) | 2.48191752 |
| 64 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.47577693 |
| 65 | fucose metabolic process (GO:0006004) | 2.46318127 |
| 66 | ethanol oxidation (GO:0006069) | 2.45971521 |
| 67 | ethanol metabolic process (GO:0006067) | 2.45324363 |
| 68 | establishment of protein localization to Golgi (GO:0072600) | 2.45323689 |
| 69 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.44684168 |
| 70 | chemical homeostasis within a tissue (GO:0048875) | 2.42999588 |
| 71 | zinc ion transport (GO:0006829) | 2.42646543 |
| 72 | cellular potassium ion homeostasis (GO:0030007) | 2.39054154 |
| 73 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.38698699 |
| 74 | intestinal absorption (GO:0050892) | 2.37742988 |
| 75 | cellular glucuronidation (GO:0052695) | 2.36716448 |
| 76 | glucosamine-containing compound catabolic process (GO:1901072) | 2.35896939 |
| 77 | surfactant homeostasis (GO:0043129) | 2.35815423 |
| 78 | negative regulation of humoral immune response (GO:0002921) | 2.35278755 |
| 79 | ectoderm development (GO:0007398) | 2.33636096 |
| 80 | sphingomyelin metabolic process (GO:0006684) | 2.33406514 |
| 81 | vesicle coating (GO:0006901) | 2.32792435 |
| 82 | cellular response to unfolded protein (GO:0034620) | 2.32473699 |
| 83 | epithelial cell maturation (GO:0002070) | 2.31655850 |
| 84 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.31653383 |
| 85 | mature B cell differentiation involved in immune response (GO:0002313) | 2.31575863 |
| 86 | regulation of vesicle fusion (GO:0031338) | 2.31263614 |
| 87 | negative regulation of complement activation (GO:0045916) | 2.30495437 |
| 88 | primary alcohol catabolic process (GO:0034310) | 2.30369378 |
| 89 | antibacterial humoral response (GO:0019731) | 2.29807943 |
| 90 | photoreceptor cell differentiation (GO:0046530) | 2.29154220 |
| 91 | eye photoreceptor cell differentiation (GO:0001754) | 2.29154220 |
| 92 | membrane repolarization (GO:0086009) | 2.28963593 |
| 93 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.28016121 |
| 94 | response to endoplasmic reticulum stress (GO:0034976) | 2.26673901 |
| 95 | lipid translocation (GO:0034204) | 2.26418874 |
| 96 | phospholipid translocation (GO:0045332) | 2.26418874 |
| 97 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.26260272 |
| 98 | innervation (GO:0060384) | 2.26253086 |
| 99 | iron ion import (GO:0097286) | 2.25539713 |
| 100 | ER-nucleus signaling pathway (GO:0006984) | 2.25207135 |
| 101 | uronic acid metabolic process (GO:0006063) | 2.23715940 |
| 102 | glucuronate metabolic process (GO:0019585) | 2.23715940 |
| 103 | regulation of ruffle assembly (GO:1900027) | 2.23284967 |
| 104 | detection of bacterium (GO:0016045) | 2.22288915 |
| 105 | regulation of nuclease activity (GO:0032069) | 2.21538512 |
| 106 | cellular response to antibiotic (GO:0071236) | 2.19923609 |
| 107 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.19690198 |
| 108 | positive regulation of exocytosis (GO:0045921) | 2.18745010 |
| 109 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.18737640 |
| 110 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.18502050 |
| 111 | intermediate filament organization (GO:0045109) | 2.17625075 |
| 112 | cellular response to topologically incorrect protein (GO:0035967) | 2.17267795 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 2.17011711 |
| 114 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.16590352 |
| 115 | smooth muscle tissue development (GO:0048745) | 2.16343587 |
| 116 | detection of other organism (GO:0098543) | 2.16135493 |
| 117 | adhesion of symbiont to host cell (GO:0044650) | 2.15847706 |
| 118 | virion attachment to host cell (GO:0019062) | 2.15847706 |
| 119 | lung secretory cell differentiation (GO:0061140) | 2.15768361 |
| 120 | glomerular filtration (GO:0003094) | 2.15639633 |
| 121 | relaxation of cardiac muscle (GO:0055119) | 2.14564936 |
| 122 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.13917643 |
| 123 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.13917643 |
| 124 | keratan sulfate catabolic process (GO:0042340) | 2.13607052 |
| 125 | icosanoid transport (GO:0071715) | 2.12482834 |
| 126 | fatty acid derivative transport (GO:1901571) | 2.12482834 |
| 127 | positive regulation of growth hormone secretion (GO:0060124) | 2.11991404 |
| 128 | insulin secretion (GO:0030073) | 2.11984722 |
| 129 | cellular copper ion homeostasis (GO:0006878) | 2.11702521 |
| 130 | phosphatidylserine metabolic process (GO:0006658) | 2.11392665 |
| 131 | epidermal cell differentiation (GO:0009913) | 2.11251545 |
| 132 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.10979316 |
| 133 | exogenous drug catabolic process (GO:0042738) | 2.10926662 |
| 134 | peptide cross-linking (GO:0018149) | 2.10773097 |
| 135 | angiotensin maturation (GO:0002003) | 2.09523017 |
| 136 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.07794905 |
| 137 | drug catabolic process (GO:0042737) | 2.06951841 |
| 138 | endothelium development (GO:0003158) | 2.04642531 |
| 139 | renal filtration (GO:0097205) | 2.03883060 |
| 140 | regulation of cholesterol homeostasis (GO:2000188) | 2.03755397 |
| 141 | alditol phosphate metabolic process (GO:0052646) | 2.02631019 |
| 142 | regulation of metalloenzyme activity (GO:0048552) | 2.01554973 |
| 143 | lipoxygenase pathway (GO:0019372) | 1.99904799 |
| 144 | cellular response to ethanol (GO:0071361) | 1.97996014 |
| 145 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 1.97955926 |
| 146 | regulation of extracellular matrix disassembly (GO:0010715) | 1.97562838 |
| 147 | positive regulation of chemokine secretion (GO:0090197) | 1.95977426 |
| 148 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 1.95769189 |
| 149 | regulation of chemokine secretion (GO:0090196) | 1.95552970 |
| 150 | primary alcohol metabolic process (GO:0034308) | 1.95197797 |
| 151 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.95108531 |
| 152 | positive regulation of extracellular matrix organization (GO:1903055) | 1.93322292 |
| 153 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.92395299 |
| 154 | adhesion of symbiont to host (GO:0044406) | 1.92377172 |
| 155 | extracellular matrix assembly (GO:0085029) | 1.92208090 |
| 156 | positive regulation of sterol transport (GO:0032373) | 1.91414919 |
| 157 | positive regulation of cholesterol transport (GO:0032376) | 1.91414919 |
| 158 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.91414621 |
| 159 | regulation of integrin-mediated signaling pathway (GO:2001044) | 1.91326474 |
| 160 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 1.88403322 |
| 161 | regulation of keratinocyte differentiation (GO:0045616) | 1.86689557 |
| 162 | negative regulation of interleukin-8 production (GO:0032717) | 1.86448220 |
| 163 | retinol metabolic process (GO:0042572) | 1.86366256 |
| 164 | epoxygenase P450 pathway (GO:0019373) | 1.85925180 |
| 165 | hair cycle (GO:0042633) | 1.85342954 |
| 166 | molting cycle (GO:0042303) | 1.85342954 |
| 167 | definitive hemopoiesis (GO:0060216) | 1.84832966 |
| 168 | peptide catabolic process (GO:0043171) | 1.84504399 |
| 169 | interleukin-1-mediated signaling pathway (GO:0070498) | 1.84041781 |
| 170 | cellular response to exogenous dsRNA (GO:0071360) | 1.83330018 |
| 171 | fibril organization (GO:0097435) | 1.83328738 |
| 172 | import into cell (GO:0098657) | 1.83227579 |
| 173 | growth hormone receptor signaling pathway (GO:0060396) | 1.82968566 |
| 174 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 1.82653333 |
| 175 | type B pancreatic cell proliferation (GO:0044342) | 1.82618579 |
| 176 | cell-substrate junction assembly (GO:0007044) | 1.82316649 |
| 177 | bile acid and bile salt transport (GO:0015721) | 1.81451626 |
| 178 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 1.81334823 |
| 179 | carnitine transport (GO:0015879) | 1.79921368 |
| 180 | amino-acid betaine transport (GO:0015838) | 1.79921368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.71064968 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.68126504 |
| 3 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.25556882 |
| 4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.05844536 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05119960 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.04910325 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04697856 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.98992586 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95625327 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95289456 |
| 11 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.88426740 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84092127 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81251191 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.78266454 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78013035 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76868659 |
| 17 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76640882 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.75421242 |
| 19 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.71613449 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70612630 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70374679 |
| 22 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.69870882 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68480166 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66758389 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.66471637 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.65663382 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65037719 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.63063609 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62794001 |
| 30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58329200 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.57381819 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.56216226 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.56216226 |
| 34 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54127711 |
| 35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51091230 |
| 36 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.50890489 |
| 37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.50659864 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49308642 |
| 39 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.49160499 |
| 40 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.48389115 |
| 41 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.47435747 |
| 42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.46778041 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45552507 |
| 44 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42825710 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40398527 |
| 46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39782828 |
| 47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37255831 |
| 48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37255831 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36741436 |
| 50 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33878499 |
| 51 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.32454793 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31281626 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30527748 |
| 54 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28756187 |
| 55 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.27416726 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26668528 |
| 57 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26196111 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26171202 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25598099 |
| 60 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25293101 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24623223 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.24496782 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24300865 |
| 64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23695081 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.23651185 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22204329 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21413594 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21302400 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21267954 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20028360 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19879179 |
| 72 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18347290 |
| 73 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16521615 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15510681 |
| 75 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15188098 |
| 76 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.14769299 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14043270 |
| 78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13971724 |
| 79 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.13919714 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13205548 |
| 81 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12930044 |
| 82 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10976117 |
| 83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10023611 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08627701 |
| 85 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06483295 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06444073 |
| 87 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06121896 |
| 88 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05653921 |
| 89 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04630849 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04594495 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03246196 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03246196 |
| 93 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.02951690 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02202615 |
| 95 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01686216 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01275974 |
| 97 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00681592 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99420864 |
| 99 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98301374 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97811330 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97170988 |
| 102 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96055510 |
| 103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95960057 |
| 104 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95401513 |
| 105 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95401513 |
| 106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95313935 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95233568 |
| 108 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95229241 |
| 109 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95228253 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95214207 |
| 111 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95054863 |
| 112 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94475225 |
| 113 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93428710 |
| 114 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93399543 |
| 115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92374434 |
| 116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91974519 |
| 117 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91913503 |
| 118 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91771336 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91220633 |
| 120 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.90925101 |
| 121 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90474753 |
| 122 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90215402 |
| 123 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90173148 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88120618 |
| 125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87717689 |
| 126 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.87586613 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87545183 |
| 128 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87234595 |
| 129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87215886 |
| 130 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86735210 |
| 131 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86734340 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86722205 |
| 133 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86519122 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86301876 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86285912 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86035935 |
| 137 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85946198 |
| 138 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85368762 |
| 139 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85107523 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84793049 |
| 141 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.84609316 |
| 142 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84600508 |
| 143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83685690 |
| 144 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82872721 |
| 145 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82835079 |
| 146 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82567253 |
| 147 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82454946 |
| 148 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82373140 |
| 149 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.81714602 |
| 150 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.81638004 |
| 151 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.81585336 |
| 152 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81196431 |
| 153 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80649350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 6.16653362 |
| 2 | MP0002796_impaired_skin_barrier | 3.89176042 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.52135959 |
| 4 | MP0001666_abnormal_nutrient_absorption | 2.90535459 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.76237167 |
| 6 | MP0010386_abnormal_urinary_bladder | 2.75911326 |
| 7 | MP0005503_abnormal_tendon_morphology | 2.64927120 |
| 8 | MP0001984_abnormal_olfaction | 2.61836942 |
| 9 | MP0008004_abnormal_stomach_pH | 2.57153862 |
| 10 | MP0005220_abnormal_exocrine_pancreas | 2.41486575 |
| 11 | MP0001958_emphysema | 2.39744144 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 2.38966928 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.38774663 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.37866993 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.34811923 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.34492955 |
| 17 | MP0010678_abnormal_skin_adnexa | 2.33640448 |
| 18 | MP0004043_abnormal_pH_regulation | 2.32562248 |
| 19 | MP0005275_abnormal_skin_tensile | 2.32440169 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.23994439 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.23134324 |
| 22 | MP0001664_abnormal_digestion | 2.20080613 |
| 23 | MP0005083_abnormal_biliary_tract | 2.12648932 |
| 24 | MP0003279_aneurysm | 2.00757625 |
| 25 | MP0005501_abnormal_skin_physiology | 1.95067126 |
| 26 | MP0003941_abnormal_skin_development | 1.95025083 |
| 27 | MP0002098_abnormal_vibrissa_morphology | 1.94797323 |
| 28 | MP0002254_reproductive_system_inflammat | 1.86921645 |
| 29 | MP0000579_abnormal_nail_morphology | 1.86403466 |
| 30 | MP0002060_abnormal_skin_morphology | 1.73377404 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.72948596 |
| 32 | MP0000383_abnormal_hair_follicle | 1.69177071 |
| 33 | MP0010771_integument_phenotype | 1.65258130 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.63741793 |
| 35 | MP0004947_skin_inflammation | 1.62989171 |
| 36 | MP0004270_analgesia | 1.61337352 |
| 37 | MP0001944_abnormal_pancreas_morphology | 1.60964340 |
| 38 | MP0002693_abnormal_pancreas_physiology | 1.57731636 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52045255 |
| 40 | MP0001216_abnormal_epidermal_layer | 1.52040464 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.50997126 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.48898754 |
| 43 | MP0000566_synostosis | 1.45961152 |
| 44 | MP0000538_abnormal_urinary_bladder | 1.42614671 |
| 45 | MP0005023_abnormal_wound_healing | 1.42610059 |
| 46 | MP0003075_altered_response_to | 1.37116642 |
| 47 | MP0001765_abnormal_ion_homeostasis | 1.36577333 |
| 48 | MP0000613_abnormal_salivary_gland | 1.35849332 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.34377340 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.33680729 |
| 51 | MP0005379_endocrine/exocrine_gland_phen | 1.33583186 |
| 52 | MP0009840_abnormal_foam_cell | 1.33525235 |
| 53 | MP0002009_preneoplasia | 1.31368219 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.31234067 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.30759870 |
| 56 | MP0003868_abnormal_feces_composition | 1.29698733 |
| 57 | MP0005409_darkened_coat_color | 1.27083783 |
| 58 | MP0001851_eye_inflammation | 1.25055041 |
| 59 | MP0004858_abnormal_nervous_system | 1.24730877 |
| 60 | MP0000377_abnormal_hair_follicle | 1.24293019 |
| 61 | MP0010368_abnormal_lymphatic_system | 1.23479251 |
| 62 | MP0003724_increased_susceptibility_to | 1.23131430 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.22116175 |
| 64 | MP0004272_abnormal_basement_membrane | 1.20303553 |
| 65 | MP0000647_abnormal_sebaceous_gland | 1.19952189 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.19329720 |
| 67 | MP0005165_increased_susceptibility_to | 1.19160527 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.17969288 |
| 69 | MP0001835_abnormal_antigen_presentation | 1.17945925 |
| 70 | MP0003252_abnormal_bile_duct | 1.17553824 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.15779403 |
| 72 | MP0000427_abnormal_hair_cycle | 1.15555446 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.15044011 |
| 74 | MP0005164_abnormal_response_to | 1.15005802 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.15004458 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.14571695 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 1.14293378 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.13509235 |
| 79 | MP0005166_decreased_susceptibility_to | 1.12684487 |
| 80 | MP0001542_abnormal_bone_strength | 1.12205390 |
| 81 | MP0005360_urolithiasis | 1.11596882 |
| 82 | MP0002184_abnormal_innervation | 1.11352215 |
| 83 | MP0001533_abnormal_skeleton_physiology | 1.11344916 |
| 84 | MP0001346_abnormal_lacrimal_gland | 1.11008726 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 1.06814534 |
| 86 | MP0000467_abnormal_esophagus_morphology | 1.06486018 |
| 87 | MP0000762_abnormal_tongue_morphology | 1.05711692 |
| 88 | MP0001968_abnormal_touch/_nociception | 1.04681821 |
| 89 | MP0005595_abnormal_vascular_smooth | 1.03727454 |
| 90 | MP0006082_CNS_inflammation | 1.03697955 |
| 91 | MP0000678_abnormal_parathyroid_gland | 1.00740455 |
| 92 | MP0003283_abnormal_digestive_organ | 1.00296051 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 0.99575780 |
| 94 | MP0003091_abnormal_cell_migration | 0.99525364 |
| 95 | MP0001970_abnormal_pain_threshold | 0.98822048 |
| 96 | MP0010329_abnormal_lipoprotein_level | 0.98474222 |
| 97 | MP0006054_spinal_hemorrhage | 0.98442695 |
| 98 | MP0003959_abnormal_lean_body | 0.97686303 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.97481884 |
| 100 | MP0001881_abnormal_mammary_gland | 0.97146400 |
| 101 | MP0002733_abnormal_thermal_nociception | 0.96975463 |
| 102 | MP0002876_abnormal_thyroid_physiology | 0.96926760 |
| 103 | MP0000470_abnormal_stomach_morphology | 0.96841769 |
| 104 | MP0002735_abnormal_chemical_nociception | 0.95877891 |
| 105 | MP0003436_decreased_susceptibility_to | 0.95303876 |
| 106 | MP0000462_abnormal_digestive_system | 0.95303309 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.94801838 |
| 108 | MP0003195_calcinosis | 0.94283617 |
| 109 | MP0004381_abnormal_hair_follicle | 0.93693011 |
| 110 | MP0003045_fibrosis | 0.93478760 |
| 111 | MP0003635_abnormal_synaptic_transmissio | 0.93253696 |
| 112 | MP0009931_abnormal_skin_appearance | 0.92238181 |
| 113 | MP0004883_abnormal_blood_vessel | 0.92011324 |
| 114 | MP0000604_amyloidosis | 0.91166330 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.90918885 |
| 116 | MP0000681_abnormal_thyroid_gland | 0.90581967 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.89511038 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.88667243 |
| 119 | MP0003828_pulmonary_edema | 0.88570187 |
| 120 | MP0005390_skeleton_phenotype | 0.88567104 |
| 121 | MP0001270_distended_abdomen | 0.88331727 |
| 122 | MP0002557_abnormal_social/conspecific_i | 0.87994166 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.85897895 |
| 124 | MP0001790_abnormal_immune_system | 0.85708994 |
| 125 | MP0005387_immune_system_phenotype | 0.85708994 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.85245016 |
| 127 | MP0004484_altered_response_of | 0.85042167 |
| 128 | MP0005508_abnormal_skeleton_morphology | 0.84813814 |
| 129 | MP0003303_peritoneal_inflammation | 0.84513185 |
| 130 | MP0008789_abnormal_olfactory_epithelium | 0.84086325 |
| 131 | MP0004782_abnormal_surfactant_physiolog | 0.83030969 |
| 132 | MP0002419_abnormal_innate_immunity | 0.82663490 |
| 133 | MP0001756_abnormal_urination | 0.82155532 |
| 134 | MP0005365_abnormal_bile_salt | 0.82133502 |
| 135 | MP0000516_abnormal_urinary_system | 0.80797881 |
| 136 | MP0005367_renal/urinary_system_phenotyp | 0.80797881 |
| 137 | MP0002272_abnormal_nervous_system | 0.78787378 |
| 138 | MP0001243_abnormal_dermal_layer | 0.78334698 |
| 139 | MP0009643_abnormal_urine_homeostasis | 0.78092153 |
| 140 | MP0000627_abnormal_mammary_gland | 0.77608155 |
| 141 | MP0002133_abnormal_respiratory_system | 0.77090899 |
| 142 | MP0005388_respiratory_system_phenotype | 0.77090899 |
| 143 | MP0005499_abnormal_olfactory_system | 0.76509498 |
| 144 | MP0005394_taste/olfaction_phenotype | 0.76509498 |
| 145 | MP0005025_abnormal_response_to | 0.76210774 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.75046788 |
| 147 | MP0002090_abnormal_vision | 0.74592966 |
| 148 | MP0002736_abnormal_nociception_after | 0.73398104 |
| 149 | MP0002118_abnormal_lipid_homeostasis | 0.73266612 |
| 150 | MP0000537_abnormal_urethra_morphology | 0.73245717 |
| 151 | MP0000631_abnormal_neuroendocrine_gland | 0.71902302 |
| 152 | MP0003866_abnormal_defecation | 0.71863193 |
| 153 | MP0001299_abnormal_eye_distance/ | 0.71694348 |
| 154 | MP0002277_abnormal_respiratory_mucosa | 0.71093534 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.69445087 |
| 156 | MP0002078_abnormal_glucose_homeostasis | 0.69315055 |
| 157 | MP0009046_muscle_twitch | 0.68981791 |
| 158 | MP0003879_abnormal_hair_cell | 0.67067304 |
| 159 | MP0000367_abnormal_coat/_hair | 0.66106732 |
| 160 | MP0002067_abnormal_sensory_capabilities | 0.65687063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Onycholysis (HP:0001806) | 4.76897045 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 4.70732439 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.04276779 |
| 4 | Pili torti (HP:0003777) | 3.98437593 |
| 5 | Alopecia of scalp (HP:0002293) | 3.71990225 |
| 6 | Fragile nails (HP:0001808) | 3.70114574 |
| 7 | Milia (HP:0001056) | 3.62367611 |
| 8 | Plantar hyperkeratosis (HP:0007556) | 3.41275102 |
| 9 | Ventricular fibrillation (HP:0001663) | 3.25811994 |
| 10 | Curly hair (HP:0002212) | 3.20211382 |
| 11 | Lip pit (HP:0100267) | 3.18775759 |
| 12 | Aortic aneurysm (HP:0004942) | 3.11806052 |
| 13 | Abnormality of the axillary hair (HP:0100134) | 3.11037117 |
| 14 | Abnormality of secondary sexual hair (HP:0009888) | 3.11037117 |
| 15 | Protrusio acetabuli (HP:0003179) | 3.08061370 |
| 16 | Woolly hair (HP:0002224) | 3.05709817 |
| 17 | Chronic bronchitis (HP:0004469) | 3.01926264 |
| 18 | Popliteal pterygium (HP:0009756) | 3.01571219 |
| 19 | Hyperactive renin-angiotensin system (HP:0000841) | 2.95989550 |
| 20 | Hypotrichosis (HP:0001006) | 2.94365036 |
| 21 | Atrophic scars (HP:0001075) | 2.88993041 |
| 22 | Hypoplasia of dental enamel (HP:0006297) | 2.83529092 |
| 23 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.81888489 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.78667617 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.78667617 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.78667617 |
| 27 | Aortic dissection (HP:0002647) | 2.77581184 |
| 28 | Follicular hyperkeratosis (HP:0007502) | 2.71457244 |
| 29 | Erythema (HP:0010783) | 2.69504096 |
| 30 | Hyperphosphatemia (HP:0002905) | 2.68518093 |
| 31 | Amelogenesis imperfecta (HP:0000705) | 2.67993512 |
| 32 | Hypothermia (HP:0002045) | 2.67392963 |
| 33 | Vascular tortuosity (HP:0004948) | 2.66310792 |
| 34 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.65195644 |
| 35 | Agitation (HP:0000713) | 2.62175440 |
| 36 | Thick nail (HP:0001805) | 2.53384593 |
| 37 | Abnormality of chloride homeostasis (HP:0011422) | 2.51103996 |
| 38 | Palmoplantar hyperkeratosis (HP:0000972) | 2.46926593 |
| 39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.46190689 |
| 40 | Gout (HP:0001997) | 2.44617071 |
| 41 | Cervical subluxation (HP:0003308) | 2.44556592 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.36596070 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.36596070 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.36596070 |
| 45 | Conjunctival hamartoma (HP:0100780) | 2.35335389 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.34599892 |
| 47 | Abnormal hair laboratory examination (HP:0003328) | 2.32110095 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.31635570 |
| 49 | Hypoplastic labia majora (HP:0000059) | 2.30777901 |
| 50 | Symptomatic seizures (HP:0011145) | 2.29781354 |
| 51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29194018 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.29194018 |
| 53 | Arterial tortuosity (HP:0005116) | 2.27727878 |
| 54 | Hyperparathyroidism (HP:0000843) | 2.27121320 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.25497933 |
| 56 | Goiter (HP:0000853) | 2.25075222 |
| 57 | Spondylolisthesis (HP:0003302) | 2.24714060 |
| 58 | Atonic seizures (HP:0010819) | 2.22495274 |
| 59 | Premature rupture of membranes (HP:0001788) | 2.19862430 |
| 60 | Decreased circulating renin level (HP:0003351) | 2.19568653 |
| 61 | Syncope (HP:0001279) | 2.18808118 |
| 62 | Palmar hyperkeratosis (HP:0010765) | 2.18478094 |
| 63 | Malnutrition (HP:0004395) | 2.15413394 |
| 64 | Exocrine pancreatic insufficiency (HP:0001738) | 2.14360114 |
| 65 | Hypodontia (HP:0000668) | 2.14152477 |
| 66 | Labial hypoplasia (HP:0000066) | 2.13798094 |
| 67 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.11290585 |
| 68 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.09416679 |
| 69 | Thoracolumbar scoliosis (HP:0002944) | 2.08998346 |
| 70 | Retinal dysplasia (HP:0007973) | 2.07727583 |
| 71 | Mitral stenosis (HP:0001718) | 2.07668367 |
| 72 | Ketoacidosis (HP:0001993) | 2.07552546 |
| 73 | Fat malabsorption (HP:0002630) | 2.03365656 |
| 74 | Vertebral compression fractures (HP:0002953) | 2.02238722 |
| 75 | Absent frontal sinuses (HP:0002688) | 2.01973072 |
| 76 | Abnormality of the labia majora (HP:0012881) | 2.01462276 |
| 77 | Cardiovascular calcification (HP:0011915) | 2.00411387 |
| 78 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.98844863 |
| 79 | Aplasia of the phalanges of the hand (HP:0009802) | 1.98844863 |
| 80 | Aplasia involving bones of the extremities (HP:0009825) | 1.98844863 |
| 81 | Wormian bones (HP:0002645) | 1.98742802 |
| 82 | Abnormal pancreas size (HP:0012094) | 1.97829569 |
| 83 | Hyperglycemia (HP:0003074) | 1.97662070 |
| 84 | Hyperkalemia (HP:0002153) | 1.97400910 |
| 85 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.96038101 |
| 86 | Complement deficiency (HP:0004431) | 1.95668693 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 1.95589050 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95337645 |
| 89 | Gingival bleeding (HP:0000225) | 1.95099434 |
| 90 | Corneal erosion (HP:0200020) | 1.94342900 |
| 91 | Ovoid vertebral bodies (HP:0003300) | 1.93746635 |
| 92 | Abdominal distention (HP:0003270) | 1.93036020 |
| 93 | Absence seizures (HP:0002121) | 1.92670788 |
| 94 | Palpitations (HP:0001962) | 1.92287996 |
| 95 | Abnormality of complement system (HP:0005339) | 1.92256913 |
| 96 | Abnormality of renin-angiotensin system (HP:0000847) | 1.90135616 |
| 97 | Hypokalemia (HP:0002900) | 1.89578666 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 1.89224480 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88482440 |
| 100 | Neuroendocrine neoplasm (HP:0100634) | 1.87778885 |
| 101 | Absent eyebrow (HP:0002223) | 1.86018820 |
| 102 | Hypoplasia of the uterus (HP:0000013) | 1.85744446 |
| 103 | Peritonitis (HP:0002586) | 1.85662001 |
| 104 | Craniofacial hyperostosis (HP:0004493) | 1.85381550 |
| 105 | Dehydration (HP:0001944) | 1.85353872 |
| 106 | Hydroxyprolinuria (HP:0003080) | 1.85009258 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 1.85009258 |
| 108 | Nephritis (HP:0000123) | 1.81982567 |
| 109 | Hoarse voice (HP:0001609) | 1.81559987 |
| 110 | Aneurysm (HP:0002617) | 1.81107869 |
| 111 | Renal salt wasting (HP:0000127) | 1.81069893 |
| 112 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.81009741 |
| 113 | Xerostomia (HP:0000217) | 1.80684922 |
| 114 | Ankyloglossia (HP:0010296) | 1.80028048 |
| 115 | Nail dystrophy (HP:0008404) | 1.78911011 |
| 116 | Neonatal short-limb short stature (HP:0008921) | 1.78795407 |
| 117 | Visual hallucinations (HP:0002367) | 1.78291011 |
| 118 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.78177035 |
| 119 | Flat acetabular roof (HP:0003180) | 1.78017230 |
| 120 | Prolonged QT interval (HP:0001657) | 1.77758395 |
| 121 | Aortic regurgitation (HP:0001659) | 1.76102118 |
| 122 | Dilatation of the ascending aorta (HP:0005111) | 1.75986514 |
| 123 | Coarse hair (HP:0002208) | 1.75946120 |
| 124 | Broad metatarsal (HP:0001783) | 1.75946053 |
| 125 | Hypoplastic female external genitalia (HP:0012815) | 1.75318370 |
| 126 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73181603 |
| 127 | Villous atrophy (HP:0011473) | 1.73181603 |
| 128 | Abnormal blistering of the skin (HP:0008066) | 1.73173750 |
| 129 | Abnormality of potassium homeostasis (HP:0011042) | 1.72955492 |
| 130 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.72879089 |
| 131 | Papilledema (HP:0001085) | 1.72103752 |
| 132 | Vascular calcification (HP:0004934) | 1.71847991 |
| 133 | Fragile skin (HP:0001030) | 1.71328931 |
| 134 | Retinal atrophy (HP:0001105) | 1.70959801 |
| 135 | Amyloidosis (HP:0011034) | 1.70493264 |
| 136 | Rhinitis (HP:0012384) | 1.70379505 |
| 137 | Abnormality of nail color (HP:0100643) | 1.70034902 |
| 138 | Asymmetric septal hypertrophy (HP:0001670) | 1.69998787 |
| 139 | Erythroderma (HP:0001019) | 1.69713283 |
| 140 | Potter facies (HP:0002009) | 1.69635102 |
| 141 | Facial shape deformation (HP:0011334) | 1.69635102 |
| 142 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69122499 |
| 143 | Mucopolysacchariduria (HP:0008155) | 1.69122499 |
| 144 | Pheochromocytoma (HP:0002666) | 1.68232934 |
| 145 | Steatorrhea (HP:0002570) | 1.68191991 |
| 146 | Hyperaldosteronism (HP:0000859) | 1.68157010 |
| 147 | Cranial hyperostosis (HP:0004437) | 1.67721974 |
| 148 | Thin bony cortex (HP:0002753) | 1.67309517 |
| 149 | Recurrent bacterial skin infections (HP:0005406) | 1.67052951 |
| 150 | Ulnar claw (HP:0001178) | 1.66623699 |
| 151 | Hypoglycemic seizures (HP:0002173) | 1.66564296 |
| 152 | Postural tremor (HP:0002174) | 1.65561081 |
| 153 | Protuberant abdomen (HP:0001538) | 1.64842667 |
| 154 | Conjugated hyperbilirubinemia (HP:0002908) | 1.64250607 |
| 155 | Increased IgE level (HP:0003212) | 1.64246960 |
| 156 | Intrahepatic cholestasis (HP:0001406) | 1.63639421 |
| 157 | Pruritus (HP:0000989) | 1.63460366 |
| 158 | Basal ganglia calcification (HP:0002135) | 1.62657952 |
| 159 | Neurofibrillary tangles (HP:0002185) | 1.62383511 |
| 160 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.61974093 |
| 161 | Metaphyseal dysplasia (HP:0100255) | 1.61878344 |
| 162 | Hamartoma of the eye (HP:0010568) | 1.61873157 |
| 163 | Action tremor (HP:0002345) | 1.61800094 |
| 164 | Hypohidrosis (HP:0000966) | 1.61730798 |
| 165 | Abnormality of the gastric mucosa (HP:0004295) | 1.61515649 |
| 166 | Hypotension (HP:0002615) | 1.61472465 |
| 167 | Adrenal overactivity (HP:0002717) | 1.60761446 |
| 168 | Bladder diverticulum (HP:0000015) | 1.58055311 |
| 169 | Interstitial pulmonary disease (HP:0006530) | 1.57571639 |
| 170 | Atrioventricular block (HP:0001678) | 1.57372548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.21355471 |
| 2 | MAP3K2 | 3.41994116 |
| 3 | MAPK15 | 3.02738213 |
| 4 | FER | 2.96720774 |
| 5 | MST1R | 2.79514551 |
| 6 | MST4 | 2.66348903 |
| 7 | WNK4 | 2.52182998 |
| 8 | INSRR | 2.39181725 |
| 9 | MAPKAPK3 | 2.36021754 |
| 10 | AKT3 | 2.23834166 |
| 11 | ERN1 | 2.13395414 |
| 12 | PIK3CG | 2.10613240 |
| 13 | EPHA2 | 2.01599764 |
| 14 | LMTK2 | 1.87268414 |
| 15 | MAP3K9 | 1.84338694 |
| 16 | STK24 | 1.71056495 |
| 17 | STK39 | 1.69871574 |
| 18 | KIT | 1.69438430 |
| 19 | RIPK4 | 1.66928245 |
| 20 | MAP2K2 | 1.61023537 |
| 21 | LATS1 | 1.59527601 |
| 22 | BCKDK | 1.57940512 |
| 23 | NTRK1 | 1.57673072 |
| 24 | JAK1 | 1.57414660 |
| 25 | NTRK3 | 1.50226503 |
| 26 | CASK | 1.42562988 |
| 27 | HIPK2 | 1.34724452 |
| 28 | DDR2 | 1.34176135 |
| 29 | GRK5 | 1.32328158 |
| 30 | TAOK3 | 1.31978495 |
| 31 | EPHA3 | 1.31721994 |
| 32 | ERBB3 | 1.29865745 |
| 33 | ARAF | 1.29208828 |
| 34 | NEK9 | 1.28756489 |
| 35 | PDGFRA | 1.25971771 |
| 36 | MAP3K1 | 1.25898168 |
| 37 | PAK3 | 1.24186047 |
| 38 | TBK1 | 1.21859989 |
| 39 | PRPF4B | 1.20869929 |
| 40 | MAP2K1 | 1.18529316 |
| 41 | PTK6 | 1.17639307 |
| 42 | MAP3K6 | 1.17490449 |
| 43 | KSR2 | 1.15871580 |
| 44 | DAPK2 | 1.15090442 |
| 45 | MAP3K3 | 1.14715129 |
| 46 | WNK1 | 1.12802213 |
| 47 | GRK6 | 1.09881897 |
| 48 | TYK2 | 1.07109142 |
| 49 | PTK2 | 1.06452055 |
| 50 | MET | 1.04103816 |
| 51 | IRAK3 | 1.03993712 |
| 52 | TEC | 1.01087717 |
| 53 | EEF2K | 1.00863313 |
| 54 | BCR | 1.00751344 |
| 55 | PDPK1 | 1.00347194 |
| 56 | RET | 0.98806972 |
| 57 | TESK1 | 0.97267628 |
| 58 | NME1 | 0.97246522 |
| 59 | PRKD2 | 0.94303981 |
| 60 | ABL2 | 0.94004806 |
| 61 | MAP3K12 | 0.92881188 |
| 62 | RPS6KA2 | 0.92766577 |
| 63 | PDGFRB | 0.92125028 |
| 64 | BLK | 0.90336928 |
| 65 | MAPK7 | 0.89783962 |
| 66 | PIK3CA | 0.89180665 |
| 67 | MAP3K14 | 0.88333613 |
| 68 | ZAP70 | 0.88277668 |
| 69 | PRKCE | 0.86481513 |
| 70 | TGFBR2 | 0.85951791 |
| 71 | PRKD3 | 0.85707278 |
| 72 | JAK3 | 0.84670310 |
| 73 | CAMK2D | 0.84583027 |
| 74 | IRAK1 | 0.83027851 |
| 75 | MAPKAPK5 | 0.82414927 |
| 76 | PAK2 | 0.82282433 |
| 77 | CAMKK2 | 0.82212930 |
| 78 | CSF1R | 0.80647774 |
| 79 | SIK1 | 0.79592957 |
| 80 | IKBKB | 0.78370376 |
| 81 | MAP3K4 | 0.78003840 |
| 82 | PDK1 | 0.76451765 |
| 83 | CDC42BPA | 0.75835756 |
| 84 | TRPM7 | 0.75214982 |
| 85 | OXSR1 | 0.75039456 |
| 86 | MAP2K4 | 0.73439121 |
| 87 | TAOK2 | 0.73332617 |
| 88 | PRKCI | 0.72509150 |
| 89 | TRIB3 | 0.71834474 |
| 90 | MAPK12 | 0.68445533 |
| 91 | MINK1 | 0.67961793 |
| 92 | PINK1 | 0.67391746 |
| 93 | PRKAA2 | 0.65783200 |
| 94 | PIM2 | 0.65064711 |
| 95 | NME2 | 0.64490361 |
| 96 | RPS6KB2 | 0.63654774 |
| 97 | STK38 | 0.62885091 |
| 98 | ERBB4 | 0.62595959 |
| 99 | DMPK | 0.61567154 |
| 100 | JAK2 | 0.60547729 |
| 101 | WNK3 | 0.59935300 |
| 102 | ABL1 | 0.59711837 |
| 103 | EPHB2 | 0.58978703 |
| 104 | PDK2 | 0.58589577 |
| 105 | CAMK2B | 0.58480188 |
| 106 | BRAF | 0.58017649 |
| 107 | BMPR1B | 0.57887529 |
| 108 | IKBKE | 0.57786617 |
| 109 | STK38L | 0.57644378 |
| 110 | NEK6 | 0.57049731 |
| 111 | ITK | 0.56538500 |
| 112 | BTK | 0.52384021 |
| 113 | SYK | 0.52030757 |
| 114 | SCYL2 | 0.51996417 |
| 115 | MAP2K6 | 0.51955616 |
| 116 | SGK223 | 0.51818659 |
| 117 | SGK494 | 0.51818659 |
| 118 | PRKG2 | 0.50577591 |
| 119 | CDK5 | 0.49972194 |
| 120 | TGFBR1 | 0.49105585 |
| 121 | MAP3K5 | 0.47762324 |
| 122 | CAMK2A | 0.47033417 |
| 123 | CAMK2G | 0.46983756 |
| 124 | GRK1 | 0.46925034 |
| 125 | FES | 0.46630608 |
| 126 | DYRK1A | 0.44689866 |
| 127 | MYLK | 0.43645491 |
| 128 | ERBB2 | 0.43578755 |
| 129 | ILK | 0.43543161 |
| 130 | PHKG2 | 0.42682322 |
| 131 | PHKG1 | 0.42682322 |
| 132 | MAPK4 | 0.42519015 |
| 133 | RIPK1 | 0.42355566 |
| 134 | CAMKK1 | 0.40768186 |
| 135 | NTRK2 | 0.40560359 |
| 136 | IRAK2 | 0.40207271 |
| 137 | MAP3K13 | 0.39819972 |
| 138 | ADRBK1 | 0.39386512 |
| 139 | PDK4 | 0.39377757 |
| 140 | PDK3 | 0.39377757 |
| 141 | FGFR3 | 0.38674287 |
| 142 | PRKD1 | 0.37059218 |
| 143 | SGK2 | 0.36650962 |
| 144 | MAP2K7 | 0.35459635 |
| 145 | EPHB1 | 0.35217240 |
| 146 | TNK2 | 0.34757775 |
| 147 | BMPR2 | 0.33240580 |
| 148 | CSNK1A1 | 0.32407891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic secretion_Homo sapiens_hsa04972 | 3.28522320 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.22350888 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.81202674 |
| 4 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.27109213 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.24049502 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 2.12050389 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.06135831 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.03518638 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00539372 |
| 10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.97768740 |
| 11 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.89529086 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.87425276 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.76993765 |
| 14 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.76206304 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73602384 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72950024 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.72119396 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67000582 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64585421 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58972417 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58417411 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57220085 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53309967 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.52704647 |
| 25 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.52112654 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.50864147 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.47571234 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.46014293 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44083754 |
| 30 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.43183283 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40498811 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.37564516 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.35712859 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.34618566 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32249447 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30649953 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.28050663 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.21241436 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20318474 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.20030640 |
| 41 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.18025429 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13741905 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.12525843 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11513305 |
| 45 | Long-term potentiation_Homo sapiens_hsa04720 | 1.10525289 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 1.09629368 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.08019227 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.05735446 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 1.04121365 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03457582 |
| 51 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03058592 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 1.02315317 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 1.02036961 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01923343 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98983366 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.98317877 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97434773 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94742169 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94108073 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91755866 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91726503 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91534031 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91389512 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90285087 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.90017098 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88739644 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88476723 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88319363 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.87614396 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.86483319 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86145909 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85796031 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84838627 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84774759 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84496782 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84126624 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83490173 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80790068 |
| 79 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.80714904 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.80533395 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79976615 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79602777 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.79576312 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.79518846 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.79094918 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.78393863 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.78310142 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78166324 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77277110 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.76407069 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75533059 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74913153 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74742268 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72395752 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71846893 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71368772 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71304978 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.70752507 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70544985 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69015336 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67521490 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67497788 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.66684719 |
| 104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66277738 |
| 105 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66027348 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64171847 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64048141 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64007594 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63544783 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63464124 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62742700 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62627083 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61619530 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58786611 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57434534 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57395360 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56942886 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56858239 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55670752 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55478841 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.54166325 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.54154679 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53326133 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52401428 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.51898066 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50845550 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50593339 |
| 128 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50589373 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50017265 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49971133 |
| 131 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49407442 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48608581 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48089382 |
| 134 | Malaria_Homo sapiens_hsa05144 | 0.47453693 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.47148008 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46200139 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45851066 |
| 138 | Adherens junction_Homo sapiens_hsa04520 | 0.44143606 |
| 139 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41617236 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41235641 |
| 141 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41196031 |
| 142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40393836 |
| 143 | Amoebiasis_Homo sapiens_hsa05146 | 0.39857130 |
| 144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39695574 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.39420625 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.38918402 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38794915 |
| 148 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37655326 |
| 149 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37030354 |
| 150 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35124488 |
| 151 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34680716 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34039016 |
| 153 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31988338 |

